The clinical stakes of the problem are considerable. Patients with sepsis occupy a peculiar intersection of risk factors for thrombosis. The same inflammatory storm that characterizes sepsis activates the coagulation cascade, endothelial damage is common, and prolonged immobility during intensive care compounds the danger. Traditional risk assessment tools, such as the widely used Padua and Caprini scores, were developed largely for general hospitalized populations and, according to the study’s authors, have shown limited effectiveness when applied to sepsis patients, whose physiology differs substantially from that of the average medical or surgical ward patient. This gap in predictive accuracy has real consequences: anticoagulation prophylaxis, the standard preventive treatment for VTE, carries its own risks of bleeding, and clinicians need to know precisely which patients warrant aggressive prevention. A tool that can reliably stratify thrombotic risk in this population could meaningfully shift the balance of preventive care.

To build their models, the research team, led by Chenglong Liang and Chen Zhou of the First Affiliated Hospital of Wenzhou Medical University, along with colleagues at several affiliated institutions, retrospectively collected data from ICU sepsis patients treated at the hospital. The dataset comprised 1,824 patients, of whom 235 developed venous thromboembolism during their ICU stay, an incidence that underscores just how prevalent the complication is in this population. The researchers divided the data temporally rather than randomly, a methodological choice designed to mimic real-world deployment. Patients admitted between 2021 and 2023 were split into a training cohort containing 70 percent of cases and a validation cohort containing the remaining 30 percent, while patients admitted from January to June 2024 served as an entirely independent test cohort, providing a rigorous check on whether the models could generalize to patients admitted after the model-building period.

Before any modeling could begin, the team confronted two of the most common pitfalls in clinical machine learning: irrelevant or redundant predictors and severely imbalanced classes. Because only a minority of sepsis patients develop VTE, a naive model could achieve superficially high accuracy simply by predicting that no one is at risk. To counter this, the researchers applied the Synthetic Minority Over-sampling Technique, or SMOTE, to the training cohort, generating synthetic examples of the minority class, patients who did develop VTE, so that the algorithms could learn the distinguishing features of both groups rather than defaulting to the majority. Feature selection proceeded in stages: univariate logistic regression was first used to screen candidate predictors, after which stepwise regression based on the Akaike Information Criterion and the least absolute shrinkage and selection operator, known as Lasso, refined the variable set. The Lasso method, in particular, shrinks the coefficients of uninformative variables toward zero, effectively performing automated variable pruning while guarding against overfitting.

The result of this selection process was a compact and clinically interpretable set of six predictors: patient age, length of stay in the ICU, duration of hospitalization before ICU admission, use of glucocorticoids, use of analgesic medications, and serum D-dimer levels. Each of these variables makes intuitive clinical sense. Older patients tend to have more compromised vascular systems and reduced mobility. Longer ICU stays mean more time exposed to the prothrombotic conditions of critical illness. Pre-ICU hospitalization duration may reflect disease severity and prolonged immobilization before intensive management began. Glucocorticoids, staples of sepsis management in many protocols, are known to influence coagulation pathways, and analgesic use may serve as a proxy for both disease burden and immobility. D-dimer, a fibrin degradation product routinely measured in critically ill patients, is a direct biochemical marker of active clot formation and breakdown, making it perhaps the most mechanistically direct of all the predictors.

Armed with these six features, the researchers constructed and compared six machine learning models spanning the spectrum of complexity from classical statistics to modern ensemble methods: logistic regression, decision tree, random forest, support vector machine, gradient boosting machine, and extreme gradient boosting. Each model was evaluated with a battery of standard performance metrics, including receiver operating characteristic curves and the area under them (AUC), calibration curves, positive and negative predictive values, true positive and true negative rates, accuracy, F1-score, and the Brier score, which quantifies the overall accuracy of probabilistic predictions. The AUC, a measure of a model’s ability to discriminate between patients who will and will not develop VTE, served as the primary basis for comparison, with values closer to 1.0 indicating stronger discrimination.

XGBoost emerged as the top performer in both the validation and test cohorts, demonstrating that its sophisticated approach, which builds an ensemble of decision trees sequentially, with each new tree trained to correct the errors of the ensemble so far, captured subtle patterns in the sepsis data that simpler models missed. In the validation cohort, the XGBoost model achieved an AUC of 0.837, with a 95 percent confidence interval of 0.79 to 0.883, placing it in the range commonly regarded as good clinical discrimination. Its performance held up reasonably well in the temporally separated test cohort, where the AUC was 0.792 (95 percent CI 0.716 to 0.869). For comparison, the other five models were also tested, but none matched XGBoost’s combination of sensitivity and specificity across the two evaluation sets.

The detailed performance metrics in each cohort reveal both the strengths and the realistic limitations of the tool. In the validation cohort, XGBoost correctly identified 73.3 percent of patients who went on to develop VTE (the true positive rate, or sensitivity) and correctly cleared 75.9 percent of those who did not (the true negative rate, or specificity). In the test cohort, sensitivity rose to 82.4 percent while specificity dipped to 70.2 percent. The negative predictive values are particularly striking: 94.8 percent in the validation cohort and 97.4 percent in the test cohort, meaning that when the model predicts a patient is at low risk, that reassurance is very often correct. Positive predictive values, at 32.4 percent and 22.8 percent respectively, were more modest, a mathematical consequence of the relatively low baseline incidence of VTE, but this matters less in a screening context where the goal is to cast a reasonably wide net while avoiding overwhelming false alarms.

The clinical implications of a high negative predictive value deserve emphasis. In an ICU setting, where every intervention carries cost and risk, a model that can reliably rule out VTE risk in the majority of patients would allow clinicians to concentrate prophylactic attention, whether that means more aggressive anticoagulation, enhanced surveillance imaging, or mechanical measures such as compression devices, on the smaller group flagged as high risk. The authors conclude that the XGBoost model demonstrated superior discriminatory ability compared with the other models and has the potential to assist clinical healthcare professionals in identifying high-risk VTE patients among those with sepsis in the ICU. Because the study was retrospective, the next step for this line of research would naturally be prospective validation, ideally in multi-center settings, to confirm that the model’s performance translates across different hospitals, patient mixes, and clinical practices.

The study also reflects a broader trend in critical care medicine: the migration of machine learning from academic curiosity to bedside decision support. Ensemble tree methods like XGBoost have become workhorses of clinical prediction because they handle nonlinear relationships, interactions between variables, and heterogeneous data types with minimal manual feature engineering. What distinguishes the current work is its disciplined methodology, temporal data splitting to test real-world generalization, principled feature selection through Lasso and information-criterion-based stepwise regression, class balancing with SMOTE, and evaluation across a comprehensive set of metrics rather than a single headline number. The research was supported by the National Natural Science Foundation of China and several Zhejiang provincial programs, and the study was approved by the Ethics Review Committee of the First Affiliated Hospital of Wenzhou Medical University, with informed consent waived due to its retrospective nature. As hospitals worldwide grapple with rising sepsis admissions and the accumulating evidence that VTE significantly worsens outcomes in these patients, tools of this kind may soon become a quiet but consequential part of the intensive care workflow, flagging the vulnerable before the clot forms.

Traditionally, the clinical identification of obesity in children hinges on snapshots of BMI measurements compared against age- and sex-specific percentiles. However, this methodology inadequately captures the persistence and trajectories of adiposity, potentially underestimating the long-term cardiometabolic risks associated with early-life obesity. The research team hypothesized that a longitudinal classification system, which tracks BMI changes over time rather than relying on isolated readings, could provide a more nuanced and prognostically valuable framework to define childhood obesity.

The study harnessed extensive real-world clinical data spanning multiple time points during childhood, accumulating a rich tapestry of BMI measurements. By algorithmically analyzing trends and patterns within individual growth curves, the researchers developed a classification system that discerns not only the current adiposity status of a child but also the trajectory and persistence of excess body weight. This nuanced approach stands in contrast to cross-sectional BMI cut-offs, which are static and potentially transient indicators.

One of the pivotal challenges in pediatric obesity research has been differentiating between children with temporary weight fluctuations and those with persistent obesity—a distinction critical for early intervention and risk stratification. The longitudinal classification system addresses this by incorporating temporal dimensions of BMI, enabling clinicians to identify subsets of children at varied risk levels based on their developmental weight patterns. Such distinctions could translate into tailored therapeutic strategies aligned with individual risk profiles.

The validation phase of the study reinforced the robustness of this novel classification. By applying the system to an independent cohort of pediatric patients, the researchers found that the longitudinal approach had superior predictive value for subsequent cardiometabolic outcomes compared to conventional cross-sectional BMI categorization. This highlights the potential for improving early diagnosis and preventative care through enhanced data-driven frameworks.

From a methodological perspective, the study’s innovation lies in leveraging longitudinal machine learning and statistical modeling techniques that accommodate the complexities of growth velocity, puberty onset, and non-linear BMI trajectories. By integrating these factors, the system moves beyond a one-size-fits-all approach and appreciates the heterogeneity inherent in childhood growth, making it a personalized tool for obesity classification.

The implications of this advancement resonate across multiple domains. For clinicians, the longitudinal BMI system offers a more dynamic and actionable insight to monitor pediatric patients. For researchers, it provides a validated framework for studying the long-term impact of childhood adiposity, facilitating more refined epidemiological and interventional studies. Meanwhile, public health policymakers gain a new lens through which to assess the burden of childhood obesity and design targeted prevention programs.

Beyond methodological novelty, the study provokes a fundamental reconsideration of how obesity’s health trajectories are defined in youth. While cross-sectional assessments have served well in population surveillance, they inadequately address individual prognoses which are essential for effective clinical decision-making. The research underscores that childhood obesity cannot be fully understood without considering its persistence over time, which acts as a stronger determinant of cardiometabolic sequelae.

This paradigm shift aligns well with emerging trends in precision medicine, emphasizing the need for longitudinal patient data and personalized risk stratification. The authors suggest that embedding such classification systems into electronic health records could enable real-time monitoring and timely clinical interventions, thereby curbing the onset of obesity-related complications in vulnerable pediatric populations.

Furthermore, the study addresses the pressing gap between clinical guidelines and real-world variability in growth patterns. Standardizing obesity classification via longitudinal trajectories could harmonize diagnostic criteria internationally, enhancing coherence across clinical trials and cohort studies—a critical stride towards global pediatric obesity research collaboration.

Among the broader ramifications, the system also offers hope for mitigating the socioeconomic and racial disparities plaguing childhood obesity. By accurately identifying children with persistent adiposity patterns early, clinicians can intervene proactively in underserved communities where access to care and preventive resources may be limited, potentially alleviating long-term health inequities.

The research team also highlights the utility of the classification system in exploring the interplay between genetic, behavioral, and environmental factors influencing obesity progression. Longitudinal data allows for disentangling these complex relationships over developmental stages, opening avenues for multifactorial intervention strategies.

Despite its promising results, the study acknowledges certain limitations, including the need for extensive longitudinal clinical data and the challenge of integrating such systems universally given varying healthcare infrastructures. Further research is warranted to optimize the classification algorithm’s applicability across diverse populations and to incorporate additional biomarkers that might refine obesity risk assessments.

As childhood obesity rates continue to climb globally amid shifting lifestyle and dietary landscapes, this study arrives as a timely and transformative contribution. It not only reframes obesity classification within pediatric care but also accentuates the critical need for continuous monitoring and early intervention to offset lifelong cardiometabolic burden.

In conclusion, the development and validation of a longitudinal clinical BMI classification system mark a pivotal advancement in pediatric obesity research and clinical practice. Its ability to capture the persistence and progression of adiposity during formative years offers a more precise gauge of health risks, potentially redefining the strategies deployed to combat the childhood obesity epidemic. The full exploration and adoption of this system could usher in a new era of personalized, predictive, and preventative pediatric healthcare.

Subject of Research: Childhood obesity classification using longitudinal BMI data and its validation.

Article Title: Classification of childhood obesity using longitudinal clinical body mass index and its validation.

Article References:
Ebrahim, N., Khadegi, A., Deng, S. et al. Classification of childhood obesity using longitudinal clinical body mass index and its validation. Int J Obes (2025). https://doi.org/10.1038/s41366-025-01836-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41366-025-01836-z

The core objective of Hu’s study was to interrogate how different versions of ChatGPT handle diagnostic tasks given real-world clinical data. Using de-identified physician notes from 30 emergency department cases, the research team prompted various ChatGPT model iterations—including GPT-3.5, GPT-4, GPT-4o, and the o1 series—to generate their top three diagnostic suggestions. The study’s methodological rigor involved comparing the models’ diagnostic precision and accuracy against actual clinical outcomes to draw a comprehensive performance profile. This approach provides a window into how AI tools can supplement, but not yet replace, human clinical judgment.

One of the profound insights emerging from this investigation is the discrepancy in AI performance between cases with classic, textbook symptoms and those with atypical or “challenging” presentations. For patients exhibiting hallmark signs of disease, ChatGPT models demonstrated promising diagnostic assistance capabilities, supporting physicians by suggesting accurate differential diagnoses. However, when confronted with complex cases lacking traditional symptomatic cues—such as pneumonia cases without accompanying fever—AI’s capacity to correctly identify diagnoses notably diminished. These failures illuminate the inherent difficulty AI models face when operating beyond their training data’s typical patterns, emphasizing the necessity for richer, more diverse datasets.

The researchers note that current AI diagnostic models primarily ingest unstructured text input—in this case, physicians’ notes—without access to multimodal clinical information. Consequently, ChatGPT’s diagnostic reasoning is limited by the breadth and variability of its textual training corpora and the information provided. Hu posits that enhancing future AI frameworks with additional clinical data streams—such as imaging results, laboratory findings, and comprehensive patient histories—could improve the fidelity and robustness of AI-assisted diagnoses in emergency contexts. Integration of these heterogeneous data types would transform AI from a purely linguistic interpreter to a more holistic clinical decision support system.

Analysis of the longitudinal performance of ChatGPT iterations reveals an interesting but cautious trajectory of improvement. While no statistically significant advance was observed when considering the inclusion of AI-generated diagnoses within the top three suggestions, the accuracy of the very top, or primary, diagnosis recommendation improved by approximately 15 to 20 percent in newer models relative to their predecessors. This subtle enhancement suggests iterative refinement in model capabilities but also highlights the persistent challenges in achieving consistently high precision necessary for clinical reliability.

The study underscores a key principle in the deployment of AI-assisted diagnostic tools: the indispensability of human oversight. Given the models’ current inadequate performance on complex cases, physician expertise remains essential to interpret AI outputs critically and corroborate or refute AI-generated hypotheses. This interplay forms a hybrid intelligence paradigm, wherein AI accelerates data synthesis and hypothesis generation while clinicians provide contextual judgment, ensuring that patient care remains both accurate and personalized.

Beyond diagnostic accuracy, Hu envisions AI modalities evolving towards greater transparency and explicability. He stresses the importance of AI systems that do not merely generate results but also reveal their reasoning pathways, enabling clinicians to understand and trust their recommendations. Such “explainable AI” is critical to fostering confidence among healthcare providers, enhancing AI’s integration into clinical workflows, and ultimately improving patient outcomes. Achieving this level of transparency will require methodological innovations in how AI models represent and communicate uncertainty and rationale.

Moreover, Hu’s research team explores imaginative avenues to augment diagnostic reasoning by leveraging multi-agent AI simulations. Drawing on prior work where ChatGPT-4 was deployed in role-playing scenarios—emulating specialists such as physiotherapists, psychologists, and nutritionists engaged in panel discussions—this approach aims to replicate the collaborative diagnostic processes typical in clinical environments. The proposed conversational model suggests that dynamic interactions among diverse AI agents could produce more nuanced, accurate diagnostic assessments, reflecting interdisciplinary integration akin to human medical teams.

Despite these promising strides, the researchers caution that current AI systems, including ChatGPT, do not qualify as certified medical devices and should not be used as standalone diagnostic solutions. In clinical settings where expanded data types, such as imaging, are incorporated, AI models must operate within secure, privacy-compliant hospital clusters as open-source platforms. Compliance with regulatory standards and patient confidentiality laws remains a non-negotiable prerequisite for AI deployment in healthcare institutions.

The study acknowledges support from the National Science Foundation and the National Institutes of Health, emphasizing the significance of federally-funded research in advancing AI applications in medicine. Additional contributors include postdoctoral fellow Jinge Wang, lab volunteer Kenneth Shue, and Li Liu from Arizona State University, reflecting a multidisciplinary collaboration essential to tackling complex problems at the intersection of computer science, bioinformatics, and clinical medicine.

Looking ahead, Hu advocates for future research to focus not only on enhancing AI’s diagnostic performance but also on its capacity to articulate reasoning in clinically meaningful ways. He suggests that improved explainability could facilitate critical emergency department decisions such as triage prioritization and treatment pathway selection, augmenting both efficiency and patient safety.

In summary, the pioneering evaluation of ChatGPT models in emergency diagnostics performed by WVU scientists reveals a nuanced landscape marked by AI’s emerging utility balanced against intrinsic challenges. While encouraging diagnostic accuracy for prototypical cases validates the promise of language models as assistive tools, persistent deficiencies in recognizing atypical disease presentations underscore the imperative for richer data integration, transparent reasoning, and robust human-AI collaboration. This research not only advances scientific understanding of AI capabilities at the clinical frontline but also charts a thoughtful course towards responsible integration of AI in patient-centered care.

Subject of Research:
Evaluation of ChatGPT AI model iterations for diagnostic assistance in emergency department patients using clinical notes.

Article Title:
Preliminary evaluation of ChatGPT model iterations in emergency department diagnostics

News Publication Date:
26-Mar-2025

Web References:

• https://www.wvu.edu/
• https://directory.hsc.wvu.edu/Profile/60888
• https://medicine.wvu.edu/
• https://medicine.wvu.edu/micro/
• https://health.wvu.edu/research-and-graduate-education/research/core-facilities/bioinformatics-core/
• https://www.nature.com/articles/s41598-025-95233-1#citeas
• http://dx.doi.org/10.1038/s41598-025-95233-1
• https://mededu.jmir.org/2024/1/e51157/

References:
Hu, G. M., Wang, J., Shue, K., Liu, L. (2025). Preliminary evaluation of ChatGPT model iterations in emergency department diagnostics. Scientific Reports. DOI: 10.1038/s41598-025-95233-1

Image Credits:
WVU Photo/Greg Ellis

Keywords:
Artificial intelligence, Disease prevention, Clinical medicine, Medical tests, Artificial consciousness, Artificial neural networks, Cognitive robotics, Forward chaining, Generative AI, Genetic algorithms, Logic based AI, Adaptive systems, Cybernetics, Robotics, Computer science

The study highlights how AI technology, trained on an extensive dataset of clinical cases, can process vast amounts of information within seconds. This capability enables AI to identify patterns and offer treatment plans based on real-world clinical data, surpassing the limitations of individual physicians who may not have access to such comprehensive datasets throughout their careers. The researchers, affiliated with notable institutions such as Tel Aviv University and Cedars-Sinai Medical Center, focused on common acute health complaints encountered during virtual primary care visits. Here, the AI system demonstrated its prowess by providing clinical recommendations that were rated more favorably than those made by human physicians.

A hallmark of the study was its deployment of expert adjudicators tasked with evaluating the performance of both AI and human recommendations. The results were revealing. In around two-thirds of cases, physicians echoed the AI’s clinical decisions. However, in the remaining cases, the AI’s recommendations were deemed superior to those made by physicians twice as often as they were considered inadequate. This suggests that while human intuition and experience remain crucial, AI can provide an often-needed enhancement, offering a second opinion that is grounded in extensive data analysis.

Moreover, the researchers emphasized that AI not only performed better in providing recommendations but also exhibited a significantly lower risk of potential harm. With only half the number of "potentially harmful" ratings compared to human decisions, it becomes clear that AI can play a critical role in mitigating risks associated with clinical decisions. This may reshape how healthcare providers approach treatments and consultations, potentially leading to improved patient safety and better health outcomes.

As AI continues to evolve, its role in clinical decision-making will likely grow even more pronounced. By adhering strictly to contemporary medical guidelines and utilizing detailed patient data, AI systems excel at recognizing subtle patterns and nuances in patient records that might elude even seasoned physicians. This capability stands to transform the landscape of primary care, allowing for more precise and personalized treatment strategies tailored to individual patient needs.

Despite its advantages, the study also serves as a reminder about the importance of caution in adopting AI technologies. An accompanying editorial from a researcher at Tufts University School of Medicine emphasizes the need for a balanced approach. While AI can significantly enhance clinical capabilities, it should not replace the human touch that is crucial in patient interaction. Physicians possess unique skills in understanding and clarifying patient symptoms during consultations—an area where AI, for now, still falls short.

The editorial suggests that integration of AI into everyday medical practice should focus on its strengths, such as confirming diagnoses and treatment plans proposed by physicians, rather than replacing them outright. Moreover, discrepancies between AI recommendations and physician judgments should prompt further investigation, leading to potential improvements in AI tools themselves. This interaction between human expertise and AI systems could foster an environment where continuous learning and adaptation become integral to the healthcare process.

As clinicians increasingly embrace AI tools in their practice, careful considerations are paramount. The study advocates for a cautious approach wherein healthcare providers remain vigilant and informed about the strengths and limitations of AI. The ultimate goal should be to foster a synergistic relationship between AI technologies and human practitioners, paralleling the advancements in medical care with the evolving landscape of technological innovation.

The implications of such advancements are profound. As healthcare systems become more complex, the combination of AI precision and human empathy could redefine the patient experience. Enhanced decision-making abilities may lead to faster diagnoses, better treatment options, and continuous monitoring, allowing for timely interventions that can drastically improve patient health outcomes and quality of life.

Beyond the bounds of primary care, the use of AI in other medical specialties holds extensive promise. From radiology to oncology, AI applications have the potential to deliver more accurate analyses and predictive outcomes through data processing capabilities that vastly surpass human limitations. In these fields, AI could assist in detecting abnormalities in imaging studies and predicting disease progression, ultimately playing an invaluable role in early intervention strategies.

As AI continues to permeate healthcare systems, ongoing research will be essential to ensure that the integration of these technologies aligns with ethical considerations and enhances the quality of care. Continuous dialogue among researchers, clinicians, and policymakers will be crucial in navigating the challenges and opportunities posed by AI. By prioritizing patient welfare and safety, the integration of AI can be steered in ways that benefit both providers and patients alike.

In summary, this study underscores the potential of AI-driven clinical recommendations in enhancing healthcare delivery. By leveraging detailed data analysis and modeling, AI can augment physician decision-making, ultimately leading to improved patient outcomes. The combination of AI abilities and human expertise holds the key to a future where healthcare is both technologically advanced and inherently compassionate.

Subject of Research: Artificial Intelligence in Clinical Decision-Making
Article Title: Artificial Intelligence Recommendations versus Physician Decisions: Comparison in Remote Visits
News Publication Date: 4-Apr-2025
Web References: Annals of Internal Medicine
References: Not Applicable
Image Credits: Not Available

Keywords: Artificial Intelligence, Healthcare, Clinical Decision-Making, Patient Outcomes, Telemedicine, Medical Guidelines, Health Technology, Chronic Illness Management.